Interpretation of management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association
10.3760/cma.j.cn115989-20230512-00175
- VernacularTitle:《ATA/ETA甲状腺眼病管理共识》解读
- Author:
Yining WEI
1
;
Huifang ZHOU
Author Information
1. 上海交通大学医学院附属第九人民医院眼科，上海 200011
- Keywords:
Thyroid Eye disease;
American Thyroid Association;
European Thyroid Association;
Consensus;
Interpretation
- From:
Chinese Journal of Experimental Ophthalmology
2023;41(11):1111-1114
- CountryChina
- Language:Chinese
-
Abstract:
Thyroid eye disease (TED) is an autoimmune disease closely related to Graves' disease and also the most common orbitopathy, which remains a challenge to diagnose and manage.In addition to the updated clinical practice guideline released by European Group on Graves' Orbitopathy in 2021 and the Chinese guideline released by Chinese Medical Association in 2022, a consensus statement was made by the American Thyroid Association and the European Thyroid Association in 2022.This consensus statement reviewed the latest research progress and clinical experience summarized from the last few decades as an aid to doctors involved in the management of TED.Further elucidation of key points from the consensus statement will be provided in this paper.
